Neurocrine Biosciences-NBIX see $40 as fair value after Indoplin news-OW@LEHM
then there's this from MSCO
Neurocrine Biosciences-NBIX shares should trade in the high teens/low $20's@MSCO The firm believes the shares will trade in this range for the next few months